Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.81−0.09 (-4.74%)
Close on Nov 18, 2026Market cap $18.06MP/E –Yield –
Atossa Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Atossa Therapeutics's revenue for the twelve months ending Sep 30, 2016 was $1.76K. For fiscal 2015 it was $1.76K, down 95.6% from the year before. The highest annual figure on record is $632.56K in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $1.76K | -95.6% |
| FY2014 | Dec 31, 2014 | $40.14K | -93.7% |
| FY2013 | Dec 31, 2013 | $632.56K | +31.3% |
| FY2012 | Dec 31, 2012 | $481.84K | +32022.8% |
| FY2011 | Dec 31, 2011 | $1.50K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?